Dyneval at London Lab Live
Why It Matters
Accurate particle and semen analytics enable better breeding efficiency and more reliable pharmaceutical manufacturing, delivering cost savings and faster product development for key industries.
Key Takeaways
- •Dinocan analyzer predicts conception rates, first of its kind.
- •Lumero provides precise particle size distributions for food and pharma.
- •Reliable particle data improves formulation and manufacturing efficiency.
- •Technology spans from farm animal breeding to industrial processing.
- •CEO emphasizes data-driven decisions for humans and machines.
Summary
Dinocan Limited’s CEO Tiffany Wood unveiled two new analytical platforms at London Lab Live: the Dinocan semen analyzer, launched in 2022, and the Lumero particle‑size analyzer, introduced this year.
The Dinocan device is the first semen analyzer that can predict conception rates, offering breeders a quantifiable metric for reproductive success. Lumero delivers highly reproducible particle‑size distributions, targeting food manufacturers and pharmaceutical firms that need precise data to fine‑tune formulations and streamline production.
Wood emphasized, “From farm to farmer we provide reliable data to help humans and machines make decisions,” highlighting use cases from livestock breeding programs to drug‑delivery particle optimization.
By turning previously opaque particle dynamics into actionable intelligence, the technologies promise higher fertility outcomes, reduced batch failures, and faster time‑to‑market, positioning Dinocan as a data‑centric player across agritech and life‑science supply chains.
Comments
Want to join the conversation?
Loading comments...